NIG
LGND icon

NFJ Investment Group’s Ligand Pharmaceuticals LGND Stock Holding History

NFJ Investment Group’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.74M Buy
13,733
+1,442
+12% +$285K 0.1% 134
2025
Q4 		$2.32M Sell
12,291
-546
-4% -$105K 0.08% 158
2025
Q3 		$2.27M Hold
12,837
– – 0.08% 179
2025
Q2 		$1.46M Sell
12,837
-80
-0.6% -$8.55K 0.05% 225
2025
Q1 		$1.36M Buy
12,917
+1,070
+9% +$121K 0.05% 238
2024
Q4 		$1.27M Buy
+11,847
New +$1.34M 0.04% 240

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

NFJ Investment Group's LGND Position: Q1 2026 in Review

NFJ Investment Group increased its Ligand Pharmaceuticals (LGND) stake by 12% in Q1 2026, buying an estimated $285K and bringing the position to 13,733 shares worth $2.74M. The position accounts for 0.1% of the portfolio, ranked #134.

NFJ Investment Group first reported a position in LGND in Q4 2024 and has held it in 6 quarters since. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.

  • NFJ Investment Group held 13,733 shares of Ligand Pharmaceuticals worth $2.74M as of Q1 2026.
  • NFJ Investment Group bought 1,442 Ligand Pharmaceuticals shares in Q1 2026, an estimated $285K.
  • Ligand Pharmaceuticals made up 0.1% of NFJ Investment Group's portfolio in Q1 2026, its #134 holding.
  • NFJ Investment Group first reported a position in Ligand Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • 357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.

Based on NFJ Investment Group's 13F filing for Q1 2026, filed 13 May 2026.